<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Musculoskelet Disord</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Musculoskelet Disord</journal-id>
      <journal-title-group>
        <journal-title>BMC Musculoskeletal Disorders</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2474</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25381065</article-id>
      <article-id pub-id-type="pmc">4236474</article-id>
      <article-id pub-id-type="publisher-id">2307</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2474-15-371</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Novel <italic>COL9A3</italic> mutation in a family diagnosed with multiple epiphyseal dysplasia: a case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Jeong</surname>
            <given-names>Changhoon</given-names>
          </name>
          <address>
            <email>chjeong@catholic.ac.kr</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Jae Young</given-names>
          </name>
          <address>
            <email>osleejy@catholic.ac.kr</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Jiyeon</given-names>
          </name>
          <address>
            <email>kjy0705@catholic.ac.kr</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chae</surname>
            <given-names>Hyojin</given-names>
          </name>
          <address>
            <email>chez@catholic.ac.kr</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Park</surname>
            <given-names>Hae-il</given-names>
          </name>
          <address>
            <email>phi@catholic.ac.kr</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Kim</surname>
            <given-names>Myungshin</given-names>
          </name>
          <address>
            <email>microkim@catholic.ac.kr</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Ok-Hwa</given-names>
          </name>
          <address>
            <email>kimoh@ajou.ac.kr</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Paul</given-names>
          </name>
          <address>
            <email>kimpaul@syntekabio.com</email>
          </address>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Young Kee</given-names>
          </name>
          <address>
            <email>leeyk@syntekabio.com</email>
          </address>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jung</surname>
            <given-names>Jongsun</given-names>
          </name>
          <address>
            <email>jung@syntekabio.com</email>
          </address>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Orthopaedic Surgery, Bucheon St. Mary&#x2019;s Hospital, The Catholic University of Korea, Seoul, South Korea </aff>
        <aff id="Aff2"><label/>Catholic Genetic Laboratory Center, Seoul St. Mary&#x2019; Hospital, The Catholic University of Korea, Seoul, South Korea </aff>
        <aff id="Aff3"><label/>Department of Laboratory Medicine, The Catholic University of Korea, Seoul, South Korea </aff>
        <aff id="Aff4"><label/>Department of Radiology, Ajou University Hospital, Suwon, South Korea </aff>
        <aff id="Aff5"><label/>Syntekabio Inc, Seoul, South Korea </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>8</day>
        <month>11</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>8</day>
        <month>11</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <volume>15</volume>
      <elocation-id>371</elocation-id>
      <history>
        <date date-type="received">
          <day>13</day>
          <month>5</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>23</day>
          <month>10</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Jeong et al.; licensee BioMed Central Ltd. 2014</copyright-statement>
        <license license-type="open-access">
          <license-p>This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Multiple epiphyseal dysplasia is a common skeletal dysplasia characterized by mild short stature, early-onset osteoarthritis mainly involving the hip and knee joints, and abnormally small and/or irregular epiphyses. Multiple epiphyseal dysplasia is clinically and genetically heterogeneous and six genes are associated with the phenotype of multiple epiphyseal dysplasia.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>A 12-year-old Korean boy presented with intermittent knee pain. His height was 144.6&#xA0;cm (20th percentile) and family history was notable for early-onset osteoarthritis in his father. The proband&#x2019;s x-rays revealed epiphyseal changes characteristic of multiple epiphyseal dysplasia associated with a collagen IX defect, with manifestations primarily restricted to the knees. Mutational analysis identified a novel c.104G&#x2009;&gt;&#x2009;A substitution in exon 2 of <italic>COL9A3</italic>, resulting in p.Gly35Asp in the proband and his father. In silico analyses predicted the p.Gly35Asp amino acid change to be detelerious, and molecular dynamics simulation demonstrated a major structural change in the heterotrimeric collagen IX.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>So far, three <italic>COL9A3</italic> mutations, have been reported. These three mutations are located at the splice donor or acceptor site of <italic>COL9A3</italic> and cause skipping of exon 3, resulting in the deletion of 12 aminoacids in the COL3 domain of COL9A3. In contrast, the novel missense mutation identified in this two-generation family with multiple epiphyseal dysplasia is a missense mutation affecting the Gly residue of the Pro-Pro-Gly repeat sequence in the COL3 domain of collage IX, with accompanying major structural change of the collagen peptide.</p>
        </sec>
        <sec>
          <title>Electronic supplementary material</title>
          <p>The online version of this article (doi:10.1186/1471-2474-15-371) contains supplementary material, which is available to authorized users.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Multiple epiphyseal dysplasia</kwd>
        <kwd>COL9A3</kwd>
        <kwd>Molecular dynamics simulation</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2014</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Multiple epiphyseal dysplasia (MED) is clinically and genetically heterogeneous group of skeletal dysplasias characterized by early-onset osteoarthritis, a waddling gait, restriction of joint mobility, pain and stiffness in the weight-bearing joints and sometimes short stature. Mutations in six different genes cause MED. Mutations in genes encoding cartilage oligomeric matrix protein (<italic>COMP</italic>), matrilin-3 (<italic>MATN3</italic>), and the alpha 1&#x2013;3 chains of type IX collagen (<italic>COL9A1</italic>, <italic>COL9A2</italic>, <italic>COL9A3</italic>) result in autosomal dominant MED [<xref ref-type="bibr" rid="CR1">1</xref>], and a specific mutation in the diastrophic dysplasia sulfate transporter (<italic>DTDST</italic>) is associated with an autosomal recessive form of MED [<xref ref-type="bibr" rid="CR2">2</xref>]. The frequencies of mutations in these genes among MED patients have yet to be determined. Previous studies in European MED patients have shown frequencies of 7&#x2013;35% for <italic>COMP</italic>, 14% for <italic>DTDST</italic>, 5&#x2013;10% for <italic>MATN3</italic>, and 5&#x2013;15% for the type IX collagen genes [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. The frequencies of causative genes showed racial differences. A comprehensive screening in a Japanese population indicated that frequencies differ in East Asian patients, with reported frequencies of 23% in <italic>MATN3</italic>, 20% in <italic>COMP</italic>, 6% in <italic>COL9A2</italic>, and none in <italic>DTDST</italic>[<xref ref-type="bibr" rid="CR5">5</xref>]. In Korean patients, <italic>MATN3</italic> mutations were found in 55% of patients, followed by <italic>COMP</italic> mutations in 41%, and <italic>COL9A2</italic> and <italic>DTDST</italic> mutations in one patients (2%), respectively [<xref ref-type="bibr" rid="CR6">6</xref>]. Genotype-phenotype correlations of MED has been described and MED resulting from collagen IX defects (<italic>COL9</italic>-MED) result in more severe involvement of the knees with relative sparing of the hips.</p>
      <p>Here we report a two-generation family with MED phenotypes consistent with <italic>COL9</italic>-MED, that were caused by a novel missense mutation in <italic>COL9A3</italic>.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <sec id="Sec3">
        <title>Patient&#x2019;s characteristics</title>
        <p>The proband was a 12-year-old Korean boy born to non-consanguineous parents. He had been treated for partial seizure disorder for 2&#xA0;years. He was referred to the pediatric orthopedic clinic for the evaluation of intermittent knee pain that had occurred for a few months. His height was 144.6&#xA0;cm (20th percentile) and bodyweight was 41&#xA0;kg (60th percentile). The height of his father and mother was 170&#xA0;cm and 160&#xA0;cm, respectively. His father also suffered from intermittent mild knee joint pain. The proband and his father did not show muscle weakness and pain suggesting myopathy. There was no Gower sign and Trendelenberg sign on physical examination. The level of creatine kinase and lactate were normal. Informed consent was obtained from the parents of the child.</p>
      </sec>
      <sec id="Sec4">
        <title>Orthopedic and radiologic evaluations</title>
        <p>Clinically, the lower extremity of the proband showed mild genu valgum deformity. The knee joints displayed full range of motion. The distal femoral and proximal tibial epiphyses were affected most, and the distal tibia and distal radius epiphyses were affected less severely. There was no irregularity on the femoral head epiphysis. Distal femoral and proximal tibial epiphyses showed loss of height, joint surface irregularities and fragmentation (Figure&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>A and B). The epiphysis of the distal tibia showed lateral shortening and fragmentation (Figure&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>C and D). There was no abnormality of the distal fibular epiphysis nor the talar dome. The tarsal navicular and cuneiform bone showed irregular ossification (Figure&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>E). The epiphysis of distal radius was wedged shape and the epiphyses of the distal ulnae were relatively small. The carpal bone shows dysplasia and flattening (Figure&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>F). The spine and the proximal femoral epiphyses appeared normal (Figure&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>G). X-rays of the proband&#x2019;s father revealed osteoarthritis of Kellgren-Lawrence grade I particularly on the medial side (Figure&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>A). However, the proximal femoral epiphyses were spared (Figure&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>B). Other members of the family were not affected.<fig id="Fig1"><label>Figure 1</label><caption><p>
<bold>Radiographs of proband at the age of 12&#xA0;years.</bold> Anteroposterior view of knee joint showed shortening, fragmentation, and joint surface irregularity of distal femoral and proximal tibial epiphysis <bold>(A, B)</bold>. Anteroposterior view of distal tibial epiphysis showed a lateral wedging and fragmentation <bold>(C, D)</bold>. The tarsal navicular and cuneiform bone showed irregular ossification <bold>(E)</bold>. The epiphysis of distal radius was wedge shaped and the epiphyses of the distal ulnae were relatively small and the carpal bone shows dysplasia and flattening <bold>(F)</bold>. The epiphyses of proximal femur were spared <bold>(G)</bold>.</p></caption><graphic xlink:href="12891_2014_Article_2307_Fig1_HTML" id="d30e496"/></fig><fig id="Fig2"><label>Figure 2</label><caption><p>
<bold>Radiographs of the proband&#x2019;s father at the age of 41&#xA0;years.</bold> Anteroposterior view of knee joints revealed early osteoarthritis with findings including of medial joint space narrowing and joint surface irregularity <bold>(A)</bold>. The capital femoral epiphysis of the proband&#x2019;s father has no evidence of dysplasia <bold>(B)</bold>.</p></caption><graphic xlink:href="12891_2014_Article_2307_Fig2_HTML" id="d30e514"/></fig></p>
      </sec>
      <sec id="Sec5">
        <title>Genetic analyses</title>
        <p>PCR from genomic DNA followed by direct sequencing was performed following parental informed consent. Genomic DNA was isolated from peripheral blood leukocytes. Direct DNA sequencing of the <italic>COMP, MANT3, COL9A1</italic>, <italic>COL9A2,</italic> and <italic>COL9A3</italic> genes was performed. All exons were amplified using the primers previously described (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). PCR amplicons were bidirectionally sequenced with the Big Dye terminator v3.1&#xA0;cycle sequencing kit (Applied Biosystems, Foster City, CA) using an ABI PRISM 3130 Genetic Analyzer (Applied Biosystems). <italic>COMP, MATN3, COL9A1</italic> and <italic>COL9A2</italic> revealed no mutations. A novel missense mutation c.104G&gt;A in exon2 of <italic>COL9A3</italic>, which resulted in p.Gly35Asp, was identified. RefSeq ID: NM_001853.3 reference sequence was used for cDNA nucleotide numbering. This mutation was predicted to be not tolerated by SIFT and probably damaging by PolyPhen [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Also, comparative evolutionary analysis showed that the glycine residue at codon 35 is a highly conserved amino acid during evolution. And the same mutation was observed in the proband&#x2019;s symptomatic father. We performed Sanger sequencing of 100 healthy controls and none harbored a c.104G&gt;A mutation in exon 2 of <italic>COL9A3.</italic><table-wrap id="Tab1"><label>Table 1</label><caption><p>
<bold>PCR primer sequences for</bold>
<bold><italic>COL9A1, COL9A2, COL9A3, COMP,</italic></bold>
<bold>and</bold>
<bold><italic>MATN3</italic></bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" colspan="4">Primer sequences</th></tr><tr><th colspan="2">
<bold><italic>COL9A1</italic></bold> gene</th><th align="center">Tm (&#xB0;C)</th><th align="center">Product size (bp)</th></tr></thead><tbody><tr><td>Exon 8-10</td><td>F - CCGATGTGCTCCACTAACCT</td><td align="center" rowspan="2">56</td><td align="center" rowspan="2">824</td></tr><tr><td/><td>R - GGCCAAGTTTAGAGCCACAG</td></tr><tr><td colspan="2">
<italic>COL9A2</italic> gene</td><td align="center"/><td align="center"/></tr><tr><td>Exon 2</td><td>F - CAGCTTCCTGCACTGTCTGA</td><td align="center" rowspan="2">56</td><td align="center" rowspan="2">241</td></tr><tr><td/><td>R - GACGAGGGGCACTACATCTC</td></tr><tr><td>Exon 3-4</td><td>F - TGAGCCGTAGTGTGCTGTCT</td><td align="center" rowspan="2">56</td><td align="center" rowspan="2">278</td></tr><tr><td/><td>R - CTGGAGGTCAATTGGCAGAG</td></tr><tr><td colspan="2">
<italic>COL9A3</italic> gene</td><td align="center"/><td align="center"/></tr><tr><td>Exon 2</td><td>F - TTTGGGTCTCACCGAGGA</td><td align="center" rowspan="2">56</td><td align="center" rowspan="2">293</td></tr><tr><td/><td>R - GCCTGGTTTTCTCTCCATCA</td></tr><tr><td>Exon 3</td><td>F - CTTGAGGGACCCCTGATTTT</td><td align="center" rowspan="2">56</td><td align="center" rowspan="2">152</td></tr><tr><td/><td>R - TGTTCTGAGTTCCCCCTTTC</td></tr><tr><td>Exon 4</td><td>F - GCATTTTGCTTCATTGCTGA</td><td align="center" rowspan="2">56</td><td align="center" rowspan="2">222</td></tr><tr><td/><td>R - AATTAGGGCCGGACTCCTC</td></tr><tr><td colspan="2">
<italic>COMP</italic> gene</td><td align="center"/><td align="center"/></tr><tr><td>Exon 8-9</td><td>F - TTGAGGCGGGGTTGGGTG</td><td align="center" rowspan="2">64</td><td align="center" rowspan="2">413</td></tr><tr><td/><td>R - ACCGTGCCGAGCCGTAGAT</td></tr><tr><td>Exon 10</td><td>F - AGGAGTGTGACCTTTGCCTTCT</td><td align="center" rowspan="2">64</td><td align="center" rowspan="2">334</td></tr><tr><td/><td>R - CTAGTCCAGCTTACCCCATCC</td></tr><tr><td>Exon 11-12</td><td>F - GAAGTCATTCTGGCCTGGTC</td><td align="center" rowspan="2">64</td><td align="center" rowspan="2">518</td></tr><tr><td/><td>R - AGCGTTTTGTCAAAGGCTACC</td></tr><tr><td>Exon 13</td><td>F - CGGGTAGCCTTTGACAAAACG</td><td align="center" rowspan="2">62</td><td align="center" rowspan="2">331</td></tr><tr><td/><td>R - GCCCGCCCACCGTAGAC</td></tr><tr><td>Exon 14-15</td><td>F - GGCGGGCCCTGACTTTAG</td><td align="center" rowspan="2">64</td><td align="center" rowspan="2">546</td></tr><tr><td/><td>R - ATAACCCCGCCCCTCTGT</td></tr><tr><td>Exon 16</td><td>F - GTTCTGGGTGCCAGGTTC</td><td align="center" rowspan="2">64</td><td align="center" rowspan="2">335</td></tr><tr><td/><td>R - AAGGGTTTTACGGAGGGTCAT</td></tr><tr><td>Exon 17</td><td>F - TGCTCCCAACTGTCTCTCCA</td><td align="center" rowspan="2">64</td><td align="center" rowspan="2">312</td></tr><tr><td/><td>R - ACCTGGGCCTGTGTGTCC</td></tr><tr><td>Exon 18-19</td><td>F - TCTGAGAGGGAAGGGTCTGG</td><td align="center" rowspan="2">64</td><td align="center" rowspan="2">443</td></tr><tr><td/><td>R - CCCTTCTCACTTCCCCCTCA</td></tr><tr><td colspan="4">
<italic>MATN3</italic> gene</td></tr><tr><td>Exon 3</td><td>F - AAAGGAGCCCAGAGAGCAAT</td><td align="center">59</td><td align="center">290</td></tr><tr><td/><td>R - CAGTCCAAAACCTGGAGCAT</td><td/><td/></tr></tbody></table></table-wrap></p>
      </sec>
      <sec id="Sec6">
        <title>Molecular Dynamics (MD) simulation of wild type and mutant model structure of trimer collagen IX</title>
        <p>Molecular mechanics potential energy minimization and MD simulations were carried out using the program package AMBER 11 [<xref ref-type="bibr" rid="CR9">9</xref>]. FF99 force field in AMBER package was used in all MD simulations including hetero atoms. Topology file GAFF force field in AMBER package was used. The generalized Born solvation model was used instead of explicit water [<xref ref-type="bibr" rid="CR10">10</xref>]. The temperature was kept constant by using Langevin dynamics with a collision frequency of 5.0&#xA0;ps<sup>&#x2212;1</sup>[<xref ref-type="bibr" rid="CR11">11</xref>]. The minimized system was heated from 0&#xA0;K to 325&#xA0;K for 50&#xA0;ps in a total of 7 stages. By heating gradually in stages, the possible crashes will be reduced by allowing it to equilibrate at each temperature. The heated systems were then subjected to molecular dynamics simulations for 1&#xA0;ns each at 325&#xA0;K in a total of 10 stages. In all simulations, the temperature was kept constant at 325&#xA0;K. The simulations were performed using the PMEMD module with GPU system which utilizes the particle mesh Ewald method [<xref ref-type="bibr" rid="CR12">12</xref>]. SHAKE algorithm was used to constrain bond lengths involving hydrogen [<xref ref-type="bibr" rid="CR13">13</xref>].The mutation of p.Gly35Asp in type IX collagen alpha 3 has a Pro-Pro-Gly consecutive residue pattern. The collagen model structure was generated with a template of 2v53 PDB (protein database bank). After the MD simulation, the wild type and mutant collagen structures were visually inspected. The wild type structure formed hydrogen bonds with its neighboring strand while the mutant was aggregated by themselves (Figure&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>A to D). In addition, the distances between the mutation site (C-alpha) of the wild type and the mutant collagen are almost twice (Figure&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>E and F). The calculated energy state of the mutant is much lower, causing a self aggregation (Figure&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>G). Considering the major structural change caused by the collagen mutant, a malfunction of the type IX collagen is expected.<fig id="Fig3"><label>Figure 3</label><caption><p>
<bold>MD simulation of wild type and mutant model structure of trimer collagen.</bold> Wild type model structure <bold>(A)</bold>, twisted form of the mutant <bold>(B)</bold>, collagen-collagen interaction by a hydrogen bonding in wild type <bold>(C)</bold>, the substitution of glycine to aspartic acid causing an interaction with the self strand <bold>(D)</bold>, C-alpha distance between residues in wild type and mutant trimer <bold>(E and F)</bold>, respectively, and energy plot of wild type and mutant collagen by Amber-GPU <bold>(G)</bold>.</p></caption><graphic xlink:href="12891_2014_Article_2307_Fig3_HTML" id="d30e965"/></fig></p>
      </sec>
    </sec>
    <sec id="Sec7">
      <title>Conclusions</title>
      <p>The clinical and radiographic phenotypes of MED vary heterogenously according to the genetic mutation. <italic>COMP</italic> and <italic>MATN3</italic> mutations show marked abnormalities in hip and knee joints. Patients with the <italic>COMP</italic> mutation have characteristics of marked alterations of hip joints leading to severe osteoarthritis in early childhood [<xref ref-type="bibr" rid="CR14">14</xref>]. The <italic>MATN3</italic> mutation has dysplastic epiphysis of the proximal and distal femur [<xref ref-type="bibr" rid="CR15">15</xref>]. Clinical features of autosomal recessive MED associated with <italic>DTDST</italic> mutations include scoliosis and abnormal findings such as clubfoot, cleft palate, cystic ear swelling, and clinodactyly are present at birth in approximately 50% of individuals [<xref ref-type="bibr" rid="CR16">16</xref>]. <italic>COL9</italic>-MED is generally the mildest form of MED and is characterized by joint pain in the hips and/or knees and stiffness presenting in the first decade of life, while radiographic abnormalities are primarily restricted to the knees with relative sparing of the hips [<xref ref-type="bibr" rid="CR4">4</xref>]. Epiphyseal flattening and irregularity of affected joint are evident. MED-related myopathy has been reported in some families with <italic>COL9A3</italic>, <italic>COMP</italic>, and <italic>COL9A2</italic> mutations [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>].</p>
      <p>We presently describe an autosomal dominant MED family with novel <italic>COL9A3</italic> mutation. The proband and his father presented with mild knee joint pain. The height of the proband was in the 20th percentile but his father&#x2019;s height was average for Korean males. Radiographs of the proband showed epiphyseal changes of MED. The knee joints were most severely affected but other joints revealed minor involvement including ankle, foot, and wrist. Sparing of hip joints, no history of clubfoot or other deformities at birth, and the pattern of inheritance distinguished their conditions from the other MED caused by <italic>COMP</italic>, <italic>MATN3</italic>, and <italic>DTDST</italic> mutations. Therefore, we analyzed the genes associated with collagen type IX on the bases of clinical and radiographic phenotypes. It is interesting that the <italic>COL9A3</italic> mutation detected in the proband and his father is a missense mutation. Previously reported <italic>COL9A3</italic> mutations were splice site acceptor or donor mutations in intron 2 or 3, that invariably resulted in skipping of exon 3 of <italic>COL9A3</italic>[<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR19">19</xref>] with deletion of 12 amino acids in the COL3 domain of COL9A3. The c.104G&gt; A substitution in exon 2 of <italic>COL9A3</italic>, resulting in p.Gly35Asp, affects the COL3 domain of COL9A3, and results in a substitution of Gly to Asp in the third position of &#x201C;Pro-Pro-Gly&#x201D; consecutive sequence. The COL3 domain is consistently affected in <italic>COL9A2</italic> and <italic>COL9A3</italic> mutations associated with MED, thus emphasizing the role of the COL3 domain in the pathogenesis of MED. Although, the novel mutation does not result in a splicing defect of the COL3 domain, it affects an important amino acid in a conserved &#x201C;Pro-Pro-Gly&#x201D; repeat sequence of the highly conserved COL3 domain.</p>
      <p>Another point of interest is that the proband had been treated for seizure disorder. A study characterizing a microdeletion of 20q13.33, a cytogenetic locus in which <italic>COL9A3</italic> is located, demonstrated that this abnormality is associated with several clinical features including mental retardation, developmental delay, speech and language deficits, behavior problems and seizures. In the study, two of six patients had deletions that encompassed <italic>COL9A3</italic> and one had seizure disorder, but they lacked in clinical features reminiscent of MED. The association between seizure and <italic>COL9A3</italic> is not clear, but the possibility should be considered. In addition, the authors remarked that the suggested deletion of <italic>COL9A3</italic> did not cause the MED symptom [<xref ref-type="bibr" rid="CR20">20</xref>]. However, we have a reservation with this opinion, because symptoms of MED caused by <italic>COL9A3</italic> mutations are mild and the patients with microdeletion at 20q13.33 had combined abnormalities in morphology and psychomotor and behavioral development. It should be defined after careful clinical and radiographic assessment.</p>
      <p>Type IX collagen is the structural component of hyaline cartilage and vitreous of the eye, and has been observed in various tissues including the notochord, inner ear, heart, brain, and skin in mice [<xref ref-type="bibr" rid="CR21">21</xref>]. Collagen IX is a hetero-trimeric molecule that consists of three &#x3B1; chains, &#x3B1;1(IX), &#x3B1;2(IX), and &#x3B1;3(IX)) in a 1:1:1 ratio. And the sizes of the domains and amino acid sequences of the &#x3B1;1(IX), &#x3B1;2(IX), and &#x3B1;3(IX) chains are highly conserved. Also the reported mutations in <italic>COL9A2</italic> and <italic>COL9A3</italic> show a remarkable consistency in affecting the COL3 domain [<xref ref-type="bibr" rid="CR22">22</xref>], and clearly indicates that the COL3 domain is a functionally important component of type IX collagen in vivo. MD simulation of heterotrimer collagen IX revealed that the wild type structure formed hydrogen bonds with its neighboring strand, while the mutant showed self-aggregation. In addition, the distances between the mutation site (C-alpha) of wild type and mutant collagen are almost twice and the calculated energy state of the mutant is much lower, causing a self-aggregation. Our results reveal that the substitution of Gly to Asp produces a large local disruption to the COL3 domain of COL9A3, enough to lead to a malfunction of the type IX collagen.</p>
      <p>Lastly, the phenotypic difference within family members was also observed but neither of the family members showed neuromuscular manifestations, a feature that has been associated in a previous MED patient with <italic>COL9A3</italic> mutation [<xref ref-type="bibr" rid="CR17">17</xref>]. It remains to be determined whether both inter- and intra-familial phenotypic diversity are common in type IX collagen mutations. As well, the relationship between MED and other neuromuscular manifestations must be clarified.</p>
    </sec>
    <sec id="Sec8">
      <title>Consent</title>
      <p>Written informed consent was obtained from the parents of the child for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.</p>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec9">
          <title>Authors&#x2019; original submitted files for images</title>
          <p>Below are the links to the authors&#x2019; original submitted files for images.<media position="anchor" xlink:href="12891_2014_2307_MOESM1_ESM.pdf" id="MOESM1"><caption><p>Authors&#x2019; original file for figure 1</p></caption></media><media position="anchor" xlink:href="12891_2014_2307_MOESM2_ESM.pdf" id="MOESM2"><caption><p>Authors&#x2019; original file for figure 2</p></caption></media><media position="anchor" xlink:href="12891_2014_2307_MOESM3_ESM.tiff" id="MOESM3"><caption><p>Authors&#x2019; original file for figure 3</p></caption></media></p>
        </sec>
      </app>
    </app-group>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>CJ and JYL diagnosed the MED and clinically examined the family members. JK, HC and HP helped with the genetic analyses and interpretation. CJ and OHK provided scientific support and valuable advice. PK, YKL and JJ performed MD simulation studies. MK reviewed the literature and wrote the manuscript. All authors have read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>We are grateful to the patient and parents assisting us in carrying out this study and compiling this report. The authors wish to acknowledge the financial support of the Catholic Medical Center Research Foundation made in the program year of 2012.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Unger</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hecht</surname>
              <given-names>JT</given-names>
            </name>
          </person-group>
          <article-title>Pseudoachondroplasia and multiple epiphyseal dysplasia: new etiologic developments</article-title>
          <source>Am J Med Genet</source>
          <year>2001</year>
          <volume>106</volume>
          <fpage>244</fpage>
          <lpage>250</lpage>
          <pub-id pub-id-type="doi">10.1002/ajmg.10234</pub-id>
          <pub-id pub-id-type="pmid">11891674</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Superti-Furga LN</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Riebel</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Eich</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Steinmann</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Spranger</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kunze</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Recessively inherited multiple epiphyseal dysplasia with normal stature, club foot, and double layered patella caused by a DTDST mutation</article-title>
          <source>J Med Genet</source>
          <year>1999</year>
          <volume>36</volume>
          <fpage>621</fpage>
          <lpage>624</lpage>
          <pub-id pub-id-type="pmid">10465113</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Briggs</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Chapman</surname>
              <given-names>KL</given-names>
            </name>
          </person-group>
          <article-title>Pseudoachondroplasia and multiple epiphyseal dysplasia: mutation review, molecular interactions, and genotype to phenotype correlations</article-title>
          <source>Hum Mutat</source>
          <year>2002</year>
          <volume>19</volume>
          <fpage>465</fpage>
          <lpage>478</lpage>
          <pub-id pub-id-type="doi">10.1002/humu.10066</pub-id>
          <pub-id pub-id-type="pmid">11968079</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jackson</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Mittaz-Crettol</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Mortier</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Spranger</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zabel</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Le Merrer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cormier-Daire</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Hall</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Offiah</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wright</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Savarirayan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Nishimura</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ramsden</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Elles</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bonafe</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Superti-Furga</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Unger</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zankl</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Briggs</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
          <article-title>Pseudoachondroplasia and multiple epiphyseal dysplasia: a 7-year comprehensive analysis of the known disease genes identify novel and recurrent mutations and provides an accurate assessment of their relative contribution</article-title>
          <source>Hum Mutat</source>
          <year>2012</year>
          <volume>33</volume>
          <fpage>144</fpage>
          <lpage>157</lpage>
          <pub-id pub-id-type="doi">10.1002/humu.21611</pub-id>
          <pub-id pub-id-type="pmid">21922596</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Itoh</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Shirahama</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nakashima</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Maeda</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Haga</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kitoh</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kosaki</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ohashi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nishimura</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ikegawa</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Comprehensive screening of multiple epiphyseal dysplasia mutations in Japanese population</article-title>
          <source>Am J Med Genet A</source>
          <year>2006</year>
          <volume>140A</volume>
          <fpage>1280</fpage>
          <lpage>1284</lpage>
          <pub-id pub-id-type="doi">10.1002/ajmg.a.31292</pub-id>
          <pub-id pub-id-type="pmid">16691584</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>OH</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Seong</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Nishimura</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Superti-Furga</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Unger</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ikegawa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>IH</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>HW</given-names>
            </name>
            <name>
              <surname>Yoo</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Shim</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>CY</given-names>
            </name>
            <name>
              <surname>Oh</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Jeong</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Seo</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>SI</given-names>
            </name>
            <name>
              <surname>Yeo</surname>
              <given-names>IK</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>HW</given-names>
            </name>
            <name>
              <surname>Yoo</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Shim</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>CY</given-names>
            </name>
            <name>
              <surname>Oh</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Jeong</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>KS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Revisit of multiple epiphyseal dysplasia: ethnic difference in genotypes and comparison of radiographic features linked to the COMP and MATN3 genes</article-title>
          <source>Am J Med Genet A</source>
          <year>2011</year>
          <volume>155A</volume>
          <fpage>2669</fpage>
          <lpage>2680</lpage>
          <pub-id pub-id-type="doi">10.1002/ajmg.a.34246</pub-id>
          <pub-id pub-id-type="pmid">21965141</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ramensky</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Bork</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sunyaev</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Human non-synonymous SNPs: server and survey</article-title>
          <source>Nucleic Acids Res</source>
          <year>2002</year>
          <volume>30</volume>
          <fpage>3894</fpage>
          <lpage>3900</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkf493</pub-id>
          <pub-id pub-id-type="pmid">12202775</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ng</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Henikoff</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Predicting deleterious amino acid substitutions</article-title>
          <source>Genome Res</source>
          <year>2001</year>
          <volume>11</volume>
          <fpage>863</fpage>
          <lpage>874</lpage>
          <pub-id pub-id-type="doi">10.1101/gr.176601</pub-id>
          <pub-id pub-id-type="pmid">11337480</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Case</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Cheatham</surname>
              <given-names>TE</given-names>
              <suffix>3rd</suffix>
            </name>
            <name>
              <surname>Darden</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Gohlke</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Luo</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Merz</surname>
              <given-names>KM</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Onufriev</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Simmerling</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Woods</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>The Amber biomolecular simulation programs</article-title>
          <source>J Comput Chem</source>
          <year>2005</year>
          <volume>26</volume>
          <fpage>1668</fpage>
          <lpage>1688</lpage>
          <pub-id pub-id-type="doi">10.1002/jcc.20290</pub-id>
          <pub-id pub-id-type="pmid">16200636</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hawkins</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Cramer</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Truhlar</surname>
              <given-names>GD</given-names>
            </name>
          </person-group>
          <article-title>Parametrized models of aqueous free energies of solvation based on pairwise descreening of solute atomic charges from a dielectric medium</article-title>
          <source>J Phys Chem</source>
          <year>1996</year>
          <volume>100</volume>
          <fpage>19824</fpage>
          <lpage>19839</lpage>
          <pub-id pub-id-type="doi">10.1021/jp961710n</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Izaguirre</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Catarello</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Wozniak</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Skeel</surname>
              <given-names>RD</given-names>
            </name>
          </person-group>
          <article-title>Langevin stabilization of molecular dynamics</article-title>
          <source>J Chem Phys</source>
          <year>2001</year>
          <volume>114</volume>
          <fpage>2090</fpage>
          <lpage>2098</lpage>
          <pub-id pub-id-type="doi">10.1063/1.1332996</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gotz</surname>
              <given-names>AW</given-names>
            </name>
            <name>
              <surname>Williamson</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Poole</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Le Grand</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>Routine microsecond molecular dynamics simulations with AMBER on GPUs. 1. Generalized born</article-title>
          <source>J Chem Theory Comput</source>
          <year>2012</year>
          <volume>8</volume>
          <fpage>1542</fpage>
          <lpage>1555</lpage>
          <pub-id pub-id-type="doi">10.1021/ct200909j</pub-id>
          <pub-id pub-id-type="pmid">22582031</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ryckaert</surname>
              <given-names>J-P</given-names>
            </name>
            <name>
              <surname>Ciccotti</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Berendsen</surname>
              <given-names>HJC</given-names>
            </name>
          </person-group>
          <article-title>Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes</article-title>
          <source>J Comput Phys</source>
          <year>1977</year>
          <volume>23</volume>
          <fpage>327</fpage>
          <lpage>341</lpage>
          <pub-id pub-id-type="doi">10.1016/0021-9991(77)90098-5</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Briggs</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Hoffman</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Olsen</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Mohrenweiser</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Leroy</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Mortier</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Rimoin</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Lachman</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Gaines</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Cekleniak</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Knowlton</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Cohn</surname>
              <given-names>DH</given-names>
            </name>
          </person-group>
          <article-title>Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene</article-title>
          <source>Nat Genet</source>
          <year>1995</year>
          <volume>10</volume>
          <fpage>330</fpage>
          <lpage>336</lpage>
          <pub-id pub-id-type="doi">10.1038/ng0795-330</pub-id>
          <pub-id pub-id-type="pmid">7670472</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chapman</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Mortier</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Chapman</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Loughlin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Grant</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Briggs</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
          <article-title>Mutations in the region encoding the von Willebrand factor A domain of matrilin-3 are associated with multiple epiphyseal dysplasia</article-title>
          <source>Nat Genet</source>
          <year>2001</year>
          <volume>28</volume>
          <fpage>393</fpage>
          <lpage>396</lpage>
          <pub-id pub-id-type="doi">10.1038/ng573</pub-id>
          <pub-id pub-id-type="pmid">11479597</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ballhausen</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bonaf&#xE9;</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Terhal</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Unger</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Bellus</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Classen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hamel</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Spranger</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zabel</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Cohn</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Cole</surname>
              <given-names>WG</given-names>
            </name>
            <name>
              <surname>Hecht</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Superti-Furga</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cole</surname>
              <given-names>WG</given-names>
            </name>
            <name>
              <surname>Hecht</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Superti-Furga</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Recessive multiple epiphyseal dysplasia (rMED): phenotype delineation in eighteen homozygotes for DTDST mutatio R279W</article-title>
          <source>J Med Genet</source>
          <year>2003</year>
          <volume>40</volume>
          <fpage>65</fpage>
          <lpage>67</lpage>
          <pub-id pub-id-type="doi">10.1136/jmg.40.1.65</pub-id>
          <pub-id pub-id-type="pmid">12525546</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bonnemann</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Cox</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Shapiro</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Feener</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Anthony</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Eyre</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Darras</surname>
              <given-names>BT</given-names>
            </name>
            <name>
              <surname>Kunkel</surname>
              <given-names>LM</given-names>
            </name>
          </person-group>
          <article-title>A mutation in the alpha 3 chain of type IX collagen causes autosomal dominant multiple epiphyseal dysplasia with mild myopathy</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2000</year>
          <volume>97</volume>
          <fpage>1212</fpage>
          <lpage>1217</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.97.3.1212</pub-id>
          <pub-id pub-id-type="pmid">10655510</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jackson</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Marcus-Soekarman</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Stolte-Dijkstra</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Verrips</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Briggs</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
          <article-title>Type IX collagen gene mutations can result in multiple epiphyseal dysplasia that is associated with osteochondritis dissecans and a mild myopathy</article-title>
          <source>Am J Med Genet A</source>
          <year>2010</year>
          <volume>152A</volume>
          <fpage>863</fpage>
          <lpage>869</lpage>
          <pub-id pub-id-type="doi">10.1002/ajmg.a.33240</pub-id>
          <pub-id pub-id-type="pmid">20358595</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakashima</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kitoh</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Maeda</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Haga</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kosaki</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mabuchi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nishimura</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ohashi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ikegawa</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Novel COL9A3 mutation in a family with multiple epiphyseal dysplasia</article-title>
          <source>Am J Med Genet A</source>
          <year>2005</year>
          <volume>132A</volume>
          <fpage>181</fpage>
          <lpage>184</lpage>
          <pub-id pub-id-type="doi">10.1002/ajmg.a.30411</pub-id>
          <pub-id pub-id-type="pmid">15551337</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Traylor</surname>
              <given-names>RN</given-names>
            </name>
            <name>
              <surname>Bruno</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Burgess</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wildin</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Spencer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ganesamoorthy</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Amor</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Hunter</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Caplan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rosenfeld</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Theisen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Torchia</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Shaffer</surname>
              <given-names>LG</given-names>
            </name>
            <name>
              <surname>Ballif</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Slater</surname>
              <given-names>HR</given-names>
            </name>
          </person-group>
          <article-title>A genotype-first approach for the molecular and clinical characterization of uncommon de novo microdeletion of 20q13.33</article-title>
          <source>PloS One</source>
          <year>2010</year>
          <volume>5</volume>
          <fpage>e12462</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0012462</pub-id>
          <pub-id pub-id-type="pmid">20805988</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nishimura</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Muragaki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hayashi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ninomiya</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Olsen</surname>
              <given-names>BR</given-names>
            </name>
          </person-group>
          <article-title>Tissue-specific expression of type IX collagen</article-title>
          <source>Ann N Y Acad Sci</source>
          <year>1990</year>
          <volume>580</volume>
          <fpage>112</fpage>
          <lpage>119</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1749-6632.1990.tb17923.x</pub-id>
          <pub-id pub-id-type="pmid">2186688</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muragaki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Mariman</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>van Beersum</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Perala</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>van Mourik</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Warman</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Olsen</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Hamel</surname>
              <given-names>BC</given-names>
            </name>
          </person-group>
          <article-title>A mutation in the gene encoding the alpha 2 chain of the fibril-associated collagen IX, COL9A2, causes multiple epiphyseal dysplasia (EDM2)</article-title>
          <source>Nat Genet</source>
          <year>1996</year>
          <volume>12</volume>
          <fpage>103</fpage>
          <lpage>105</lpage>
          <pub-id pub-id-type="doi">10.1038/ng0196-103</pub-id>
          <pub-id pub-id-type="pmid">8528240</pub-id>
        </element-citation>
      </ref>
      <ref-list id="BSec1">
        <title>Pre-publication history</title>
        <ref id="CR23">
          <mixed-citation publication-type="other">The pre-publication history for this paper can be accessed here:<ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2474/15/371/prepub">http://www.biomedcentral.com/1471-2474/15/371/prepub</ext-link></mixed-citation>
        </ref>
      </ref-list>
    </ref-list>
  </back>
</article>
</pmc-articleset>
